Hereditary nonpolyposis colorectal cancer (Lynch syndrome): An updated review

Cancer

Volumn 78, Issue 6, 1996, Pages 1149-1167

  Lynch, Henry T ^a,b   Smyrk, Thomas ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

genetic counseling; hereditary nonpolyposis colorectal cancer; management; microsatellite alterations; mutator genes; surveillance

Indexed keywords

DNA;

BASE MISPAIRING; CANCER RISK; COLORECTAL CANCER; DNA REPAIR; FAMILIAL CANCER; GENE MUTATION; GENETIC COUNSELING; GENOTYPE; HUMAN; INHERITANCE; MUTATOR GENE; ONSET AGE; PEDIGREE; PENETRANCE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SYNDROME DELINEATION;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DISEASE PROGRESSION; DNA REPAIR; FEMALE; GENES; GENETIC COUNSELING; GENOTYPE; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; POPULATION SURVEILLANCE; RISK FACTORS;

EID: 0029833872     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960915)78:6<1149::AID-CNCR1>3.0.CO;2-5     Document Type: Review

References (125)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996;65:5-27.
2. Warthin AS. Heredity with reference to carcinoma. Arch Intern Med 1913;12:546-55.
3. Warthin AS. The further study of a cancer family. J Cancer Res Clin Oncol 1925;9:279-86.
4. Warthin AS. Heredity of carcinoma in man. Ann Intern Med 1931;4:681-96.
5. Lynch HT, Krush AJ. Cancer family "G" revisited:1895-1970. Cancer 1971;27:1505-11.
6. Lynch HT, Shaw MW, Magnuson CW, Larsen AL, Krush AJ. Hereditary factors in cancer. Study of two large midwestern kindreds. Arch Intern Med 1966;117:206-12.
7. Itoh H, Houlston RS, Harocopos C, Slack J. Risk of cancer death in first-degree relatives of patients with hereditary nonpolyposis cancer syndrome (Lynch Type II):a study of 130 kindreds in the United Kingdom. Br J Surg 1990; 77:1367-70.
8. Jass JR, Stewart SM, Schroeder D, Lane MR. Screening for hereditary nonpolyposis colorectal cancer in New Zealand. Eur J Gastroenterol Hepatol 1992;4:523-7.
9. Vasen HF, Hartog Jager FCA, Menko FH, Nagengast FM. Screening for hereditary nonpolyposis colorectal cancer:a study of 22 kindreds in the Netherlands. Am J Med 1989; 86:278-81.
10. Ponz de Leon M, Sassatelli R, Sacchetti C, Zanghieri G, Sealmat A, Roncucci L. Familial aggregation of tumors in the three year experience of a population-based colorectal cancer registry. Cancer Res 1989;49:4344-8.
11. Abusamra H, Maximova S, Bar-Meir S, Krispin M, Rotmensch HH. Cancer family syndrome of Lynch. Am J Med 1987;83:981.
12. Mecklin J, Jarvinen HJ, Peltokallio P. Cancer family syndrome. Genetic analysis of 22 Finnish kindreds. Gastroenterology 1986;30:328-33.
13. Mecklin JP. Frequency of hereditary colorectal carcinoma. Gastroenterology 1987;93:1021-5.
14. Rhyu MS. Molecular mechanisms underlying hereditary nonpolyposis colorectal carcinoma. J Natl Cancer Inst 1996; 88:240-51.
15. Chung DC, Rustgi AK. DNA mismatch repair and cancer. Gastroenterology 1995;109:1685-99.
16. Li G, Modrich P. Restoration of mismatch genes to nuclear extracts of H6 colorectal tumor cells by a heterodimer of MUTL homologues. PNAS 1995;92:1950-4.
17. Peltomaki P, Aaltonen L, Sistonen P, Pylkkanen L, Mecklin J, Jarvinen H, et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science 1993;260:810-2.
18. Lindblom A, Tannergard P, Werelius B, Nordenskjold M. Genetic mapping of a second locus predisposing to hereditary nonpolyposis colorectal cancer. Nat Genet 1993;5:279-82.
19. Ionov YM, Peinado A, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993;363:558-61.
20. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-9.
21. Peltomaki P, Lothe RA, Aaltonen LA, Pylkkanen L, Nystrom-Lahti M, Seruca R, et al. Microsatellite instability is associated with tumors that characterize the hereditary nonpolyposis colorectal carcinoma syndrome. Cancer Res 1993; 53:5853-5.
22. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin J, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-6.
23. Strand M, Prolla TA, Liskay RM, Petes TD. Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature 1993;365:274-6.
24. Fishel R, Lescoe MK, Rao MRS, Copeland NG, Jenkins NA, Garber J, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75:1027-38.
25. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, et al. Mutations of a MutS homolog in hereditary non-polyposis colorectal cancer. Cell 1993;75:1215-35.
26. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994;368:258-61.
27. Papadopoulos N, Nicolaides NC, Wei Y, Ruben SM, Carter KC, Rosen CA, et al. Mutation of a mutL homolog in hereditary colon cancer. Science 1994;262:1625-9.
28. Palombo F, Gillinari P, Iaccarino I, Lettieri T, Hughes M, D'Arrigo A, et al. GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. Science 1995; 268:1912-4.
29. Nicolaides NC, Papadopoulos N, Liu B, Wei Y, Carter KC, Ruben SM, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994;271:75-80.
30. Liu B, Parsons R, Papadopoulos N, Nicolaides NC, Lynch HT, Watson P, et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 1996;2:169-74.
31. Parsons R, Li G, Longley MJ, Fang W, Papadopoulos N, Jen J, et al. Hypermutability and mismatch repair deficiency in RER+ tumors cells. Cell 1993;75:1227-36.
32. Jass JR, Edgar S. Unicryptal loss of heterozygosity in hereditary nonpolyposis colorectal cancer. Pathology 1994;26:414-7.
33. Hemminki A, Peltomäki P, Mecklin J-P, Järvinen H, Salovaara R, Nyström-Lahti M, et al. Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer. Nat Genet 1994;8:405-10.
34. Parsons R, Li G, Longley M, Modrich P, Lui B, Berk T, et al. Mismatch repair deficiency in phenotypically normal human cells. Science 1995;268:738-40.
35. Umar A, Boyer JC, Thomas DC, Nguyen DC, Risinger JI, Boyd J, et al. Defective mismatch repair in extracts of colorectal and endometrial cancer cell lines exhibiting microsatellite instability. J Biol Chem 1994;269:14367-70.
36. Koi M, Umar A, Chauhan DP, Cherian SP, Carethers JM, Kunkel TA, et al. Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces loose N-methyl-N-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation (published erratum appears in Cancer Res 1994;55:201). Cancer Res 1994;54:4308-12.
37. Shibata D, Peinado MA, Ionov Y, Malkhosyan S, Perucho M. Genomic instability in repeated sequences is an early somatic event in colorectal carcinoma cell lines. Nature Genetics 1994;6:273-81.
38. Bhattacharyya NP, Skandalis A, Ganesh A, Groden J, Meuth M. Mutator phenotypes in human colorectal carcinoma cell lines. Proc Natl Acad Sci USA 1994;91:6319-23.
39. Loeb LA. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 1991;51:3075-9.
40. Strickler JG, Zheng J, Shu Q, Burgart LJ, Alberts SR, Shibata D. p53 mutations and microsatellite instability in sporadic gastric cancer:when guardians fail. Cancer Res 1994; 54:4750-5.
41. Uchida T, Wada C, Wang C, Egawa S, Ohtani H, Koshiba K. Genomic instability of microsatellite repeats and mutations of H-, K-, and N-ras, and p53 genes in renal cell carcinoma. Cancer Res 1994;54:3682-5.
42. Parsons R, Myeroff L, Liu B, Wilson JKV, Markowitz S, Kinzler KW, et al. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res 1995;55:5548-50.
43. 2 cell cycle checkpoint. Cancer Res 1995;55:3721-5.
44. Reitmair AH, Schmits R, Ewel A, Bapat B, Redston M, Mitri A, et al. MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nat Genet 1995;11:64-70.
45. Lothe RA, Peltomaki P, Meling GI, Aaltonen LA, Nystrom-Lahti M, Pylkkanen L, et al. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 1993;53:5849-52.
46. Kim H, Jen J, Vogelstein B, Hamilton SR. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences. Am J Pathol 1994;145:148-56.
47. Risinger JI, Berchuck A, Kohler MF, Watson P, Lynch HT, Boyd J. Genetic instability of microsatellites in endometrial carcinoma. Cancer Res 1993;53:5100-3.
48. Mironov NM, Aguelon M, Potapova GI, Omori Y, Gorbunov OV, Klilmenkov AA, et al. Alterations of (CA)n DNA repeats and tumor suppressor genes in human gastric cancer. Cancer Res 1994;54:41-4.
49. Han HJ, Yanagisawa A, Kato Y, Park JG, Nakamura Y. Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. Cancer Res 1993;53:5087-9.
50. Gao X, We N, Grignon D, Zacharek A, Liu H, Salkowski A, et al. High frequency of mutator phenotype in human prostatic adenocarcinoma. Oncogene 1994;9:2999-3003.
51. Yee CJ, Roodi N, Verrier CS, Parl FF. Microsatellite instability and loss of heterozygosity in breast cancer. Cancer Res 1994;54:1641-4.
52. Merlo A, Mabry M, Gabrielson E, Vollmer R, Baylin SF, Sidransky D. Frequent microsatellite instability in primary small cell lung cancer. Cancer Res 1994;54:2098-101.
53. Liu B, Nicolaides NC, Markowitz S, Willson JKV, Parsons RE, Jen J, et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet 1995;9:48-55.
54. Katabuchi H, van Rees B, Lambers AR, Ronnett BM, Blazes MS, Leach FS, et al. Mutations in DNA mismatch repair genes are not responsible for microsatellite instability in most sporadic endometrial carcinomas. Cancer Res 1995; 55:5556-60.
55. Fresco JR, Alberts BM. The accommodation of non-complementary bases in helical polyribonucleotide and deoxyribonucleic acids. Proc Natl Acad Sci USA 1960;46:311-21.
56. Streisinger G, Okada Y, Emrich J, Newton J, Tsugita A, Terzaghi E, et al. Frameshift mutations and the genetic code. Cold Spring Harb Symp Quant Biol 1966;31:77-84.
57. Wildberg J, Meselson M. Mismatch repair in heteroduplex DNA. Proc Natl Acad Sci USA 1975;72:2202-6.
58. Wagner RJ, Meselson M. Repair tracts in mismatched DNA heteroduplexes. Proc Natl Acad Sci USA 1976;73:4135-9.
59. White RL, Fox MS. Genetic consequences of transfection with heteroduplex bacteriophage lambda DNA. Mol Gen Genet 1977;141:163-71.
60. Lynch HT, Albano WA, Recabaren J, Lynch PM, Lynch JF, Elston RC. Prolonged survival as a component of hereditary breast and nonpolyposis colon cancer. Med Hypotheses 1981;7:1201-9.
61. Lu AL, Clark S, Modrich P. Methyl-directed repair of DNA base-pair mismatches in vitro. Proc Natl Acad Sci USA 1983;80:4639-43.
62. Boland CR, Troncale FJ. Familial colonie cancer without antecedent polyposis. Ann Intern Med 1984;100:700-1.
63. Jiricny J, Hughes M, Corman N, Rudkin BB. A human 200-kDa protein binds selectively to DNA fraagments containing G.T mismatches. Proc Natl Acad Sci USA 1988;85:8860-4.
64. Holmes JJ, Clark S, Modrich P. Strand-specific mismatch correction in nuclear extracts of human and drosophila melanogaster cell lines. Proc Natl Acad Sci USA 1990;87:5837-41.
65. Thomas DC, Roberts JD, Kunkel TA. Heteroduplex repair in extracts of human HeLa cells. J Biol Chem 1991;266:3744-51.
66. Bishop DK, Andersen J, Kolodner RD. Specificity of mismatch repair following transformation of saccharomyces cerevisiae with heteroduplex plasmid DNA. Proc Natl Acad Sci USA 1989;86:3713-7.
67. Kramer B, Kramer W, Williamson MS. Heteroduplex DNA correction in saccharomyces cerevisiae is mismatch specific and requires functional PMS genes. Mol Cell Biol 1989;9:4432-40.
68. Kramer W, Kramer B, Willilamson MS. Cloning and nucleotide sequence of DNA mismatch repair gene PMS1 from saccharomyces cerevisiae:homology of PMS1 to procaryotic MutL and HexB. J Bacteriol 1989;171:5339-46.
69. Vasen HFA, Mecklin J-P, Meerakhan P, Lynch HT. The international collaborative group on hereditary nonpolyposis colorectal cancer. Dis Colon Rectum 1991;34:424-5.
70. Vasen HFA, Nagengast FM, Khan PM. Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome). Lancet 1995;345:1183-4.
71. Mecklin J, Järvinen HJ, Hakkiluoto A, Hallikas H, Hiltunen K-M, Härkönen N, et al. Frequency of hereditary nonpolyposis colorectal cancer:a prospective multicenter study in Finland. Dis Colon Rectum 1995;38:588-93.
72. Jarvinen HJ, Mecklin J, Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 1995;108:1405-11.
73. Ponz de Leon M, Sassatelli R, Benatti P, Roncucci L. Identification of hereditary nonpolyposis colorectal cancer in the general population:the 6-year experience of a population-based registry. Cancer 1993;71:3493-501.
74. Kee F, Collins BJ. How prevalent is cancer family syndrome? Gut 1991;32:509-12.
75. Stephenson BM, Finan JP, Gascoyne J, Garbett F, Murday VA, Bishop DT. Frequency of familial colorectal cancer. Br J Surg 1991;78:1162-6.
76. Modica S, Roncucci L, Benatti P, Gafa L, Tamassia MG, Dardanoni L, et al. Familial aggregation of tumors and detection of hereditary non-polyposis colorectal cancer in 3-year experience of 2 population-based colorectal-cancer registries. Int J Cancer 1995;62:685-90.
77. Bailey-Wilson JE, Elston RC, Schuelke GS, Kimberling W, Albano W, Lynch JF, et al. Segregation analysis of hereditary nonpolyposis colorectal cancer. Genet Epidemiol 1986;3:27-38.
78. Scapoli C, Ponz de Leon M, Sassatelli R, Benatti P, Roncucci L, Collins A, et al. Genetic epidemiology of hereditary non-polyposis colorectal cancer syndromes in Modena, Italy: results of a complex segregation analysis. Ann Hum Genet 1994;58:275-95.
79. Vasen HFA, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffioen G, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996;110:1020-7.
80. Lynch HT, Follett KL, Lynch PM, Albano WA, Mailliard JL, Pierson RL. Family history in an oncology clinic. Implications for cancer genetics. JAMA 1979;242:1268-72.
81. Lynch HT. Cancer and the family history trail. N Y State J Med 1991;91:145-7.
82. Lynch HT, Smyrk TC, Watson P, Lanspa SJ, Lynch JF, Lynch PM, et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer:an updated review. Gastroenterology 1993;104:1535-49.
83. Love RR, Morrisey JF. Colonoscopy in asymptomatic individuals with a family history of colorectal cancer. Arch Intern Med 1984;144:2209-11.
84. Lanspa SJ, Jenkins JX, Watson P, Smyrk TC, Cavalieri RJ, Lynch JF, Lynch HT. Natural history of at-risk Lynch Syndrome family members with respect to adenomas. Nebr Med J 1992;77:310-13.
85. Green SE, Chapman PD, Burn J, Bishop DT, Varma JS. Clinical impact of colonoscopic screening in first-degree relatives of patients with hereditary nonpolyposis colorectal cancer. Br J Surg 1995;82:1338-40.
86. Love RR. Adenomas are precursor lesions for malignant growth in nonpolyposis hereditary carcinoma of the colon and rectum. Surg Gynecol Obstet 1986;162:8-12.
87. Lynch HT, Smyrk T, Jass JR. Hereditary nonpolyposis colorectal cancer and colonic adenomas:aggressive adenomas? Semin Surg Oncol 1995;11:406-10.
88. Jass JR, Stewart SM. Evolution of hereditary non-polyposis colorectal cancer. Gut 1992;33:783-6.
89. Lanspa SJ, Jenkins JX, Cavalieri J, Smyrk TC, Watson P, Lynch J, et al. Surveillance in Lynch syndrome: how aggressive? Am J Gastroenterol 1994;89:1978-80.
90. Sankila R, Aaltonen LA, Jarvinen HJ, Mecklin J. Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology 1996;110:682-7.
91. Winawer S, Zauber AG, O'Brien MJ, Ho MN, Gottlieb L, Sternberg SS, et al. National Polyp Study Workgroup. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N Engl J Med 1993;328:901-6.
92. Jacoby RF, Marshall DF, Kailas S, Schlack S, Harms B, Love R. Genetic instability with adenoma to carcinoma progression in hereditary nopolyposis colon cancer. Gastroenterology 1995;109:73-82.
93. Faragher IG, Cox CJ, Stevenson A. Hereditary nonpolyposis colorectal cancer (Lynch syndrome I) in a 13-year-old male. Aust N Z J Surg 1993;63:494-6.
94. Van de Water NS, Stewart SM, Jeevarmam P, Lane MR, Browett PJ, Jass JR. Direct mutational analysis in a family with hereditary nonpolyposis colorectal cancer. Aust N Z J Med 1994;24:682-6.
95. Westlake PJ, Bryant HE, Huchcroft SA, Sutherland LR. Frequency of hereditary nonpolyposis colorectal cancer in southern Alberta. Dig Dis Sci 1991;36:1441-7.
96. Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med 1990;113:779-88.
97. Smyrk TC, Lynch HT, Watson PA, Appelman HD. Histologic features of hereditary nonpolyposis colorectal carcinoma. In: Utsunomiya J, Lynch HT, editors. Hereditary colorectal cancer. Tokyo: Springer-Verlag, 1990:357-362
98. Mecklin JP, Jarivnen HJ. Clinical features of colorectal carcinoma in Cancer Family syndrome. Dis Colon Rectum 1986;29:160-4.
99. Jass JR, Smyrk TC, Stewart SM, Lane MR, Lanspa SJ, Lynch HT. Pathology of hereditary nonpolyposis colorectal cancer. Anticancer Res 1994;14:1631-4.
100. Lynch HT, Watson P, Kriegler M, Lynch JF, Lanspa SJ, Marcus J, et al. Differential diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome I and Lynch syndrome II). Dis Colon Rectum 1988;31:372-7.
101. Mecklin J-P. Molecular genotype/clinical phenotype relationship in HNPCC [abstract]. X 1994;38-9. (Abstract) Genetics of FAP & HNPCC. Proceedings of the fifth workshop, Budapest, Hungary. Khan PM & Mohr J (editors).
102. Watson P, Vasen HF, Mecklin JP, Jarvinen H, Lynch HT. The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer. Am J Med 1994;96:516-20.
103. Watson P, Lynch HT. Extracolonic cancer in hereditary non-polyposis colorectal cancer. Cancer 1993;71:677-85.
104. Hamilton SR, Liu B, Parsons RE, Papadopoulos N, Jen J, Powell SM, et al. The molecular basis of Turcot's syndrome. N Engl J Med 1995;332:839-47.
105. Love RR. Small bowel cancers, B-cell leukemia, and six primary cancers with matastases and prolonged survival in the Cancer Family Syndrome of Lynch. Cancer 1985;55:499-502.
106. Law IP, Herberman RB, Oldham RK, Bouzoukis J, Hanson SM, Rhode MC. Familial occurrence of colon and uterine carcinoma and of lymphoproliferative malignancies:clinical description. Cancer 1977;39:1224-8.
107. Reinbach D, McGregor JR, O'Dwyer PJ, George WD. Synchronous male breast carcinoma and soft tissue sarcoma occurring within a cancer family. Eur Oncol 1992;18:624-6.
108. Maher ER, Morson B, Beach R, Hodgson SV. Phenotypic variation in hereditary nonpolyposis colon cancer syndrome: association with infiltrative fibromatosis (desmoids tumor). Cancer 1992;69:2049-51.
109. Lynch HT, Kriegler M, Christiansen TA, Smyrk T, Lynch JF, Watson P. Laryngeal carcinoma in a Lynch syndrome II kindred. Cancer 1988;62:1007-13.
110. Muir EG, Bell AJ, Barlow KA. Multiple primary carcinomata of the colon, duodenum, and larynx associated with keratoacanthomata of the face. Br J Surg 1966;54:191-5.
111. Torre D. Multiple sebaceous tumors. Arch Dermatol 1968;98:549-51.
112. Lynch HT, Lynch PM, Pester J, Fusaro RM. The cancer family syndrome:rare cutaneous phenotypic linkage of Torre's syndrome. Arch Intern Med 1981;141:607-11.
113. Lynch HT, Fusaro RM, Roberts L, Voorhees GJ, Lynch JF. Muir-Torre syndrome in several members of a family with a variant of the Cancer Family Syndrome. Br J Dermatol 1985;113:295-301.
114. Lynch HT, Fusaro RM. Muir-Torre Syndrome: heterogeneity, natural history, diagnosis, and management. Probl Gen Surg 1993;10:1-14.
115. Hall NR, Murday VA, Chapman P, Williams MAT, Burn J, Finan PJ, et al. Genetic linkage in Muir-Torre syndrome to the same chromosomal region as cancer family syndrome. Eur J Cancer 1994;30A:180-2.
116. Cohen PR, Kohn SR, Kurzrock R. Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome. Am J Med 1991;90:606-613.
117. Lynch HT, Bardawil WA, Harris RE, Lynch PM, Guirgis HA, Lynch JF. Multiple primary cancers and prolonged survival: familial colonic and endometrial cancers. Dis Colon Rectum 1978;21:165-8.
118. Albano WA, Lynch HT, Recabaren JA, Organ CH, Mailliard JA, Black LE. Familial cancer in an oncology clinic. Cancer 1981;47:2113-8.
119. Lynch HT, Smyrk T, Lanspa SJ, Marcus JN, Kriegler M, Lynch JF, et al. Flat adenomas in a colon cancer-prone kindred. J Natl Cancer Inst 1988;80:278-82.
120. Spirio L, Otterud B, Stauffer D, Lynch H, Lynch P, Watson P, et al. Linkage of a variant or attenuated form of adenomatous polyposis coli to the adenomatous polyposis coli (APC) locus. Am J Hum Genet 1992;51:92-100.
121. Spirio L, Olschwang S, Groden J, Robertson M, Samowitz W, Joslyn G, et al. Alleles of the APC gene: an attenuated form of familial polyposis. Cell 1993;75:951-7.
122. Lynch HT, Smyrk T, McGinn T, Lanspa S, Cavalieri J, Lynch J, et al. Attenuated familial adenomatous polyposis (AFAP). A phenotypically and genotypically distinctive variant of FAP. Cancer 1995;76:2427-33.
123. Luce MC, Marra G, Chauhan DP, Laghi L, Carethers JM, Cherian SP, et al. In vitro transcription/translation assay for the screening of hMLH1 and hMSH2 mutations in familial colon cancer. Gastroenterology 1995;109:1367-73.
124. American Society of Human Genetics Board of Directors and the American College of Medical Genetics Board of Directors. Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet 1995;57:1233-41.
125. Smith KR, Croyle RT. Attitudes toward genetic testing for colon cancer risk. Am J Public Health 1995;85:1435-8.